JP2010259439A5 - - Google Patents

Download PDF

Info

Publication number
JP2010259439A5
JP2010259439A5 JP2010148212A JP2010148212A JP2010259439A5 JP 2010259439 A5 JP2010259439 A5 JP 2010259439A5 JP 2010148212 A JP2010148212 A JP 2010148212A JP 2010148212 A JP2010148212 A JP 2010148212A JP 2010259439 A5 JP2010259439 A5 JP 2010259439A5
Authority
JP
Japan
Prior art keywords
vector
gene
resistance gene
nucleic acid
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010148212A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010259439A (ja
Filing date
Publication date
Priority claimed from GB0108605A external-priority patent/GB0108605D0/en
Priority claimed from GB0109335A external-priority patent/GB0109335D0/en
Application filed filed Critical
Publication of JP2010259439A publication Critical patent/JP2010259439A/ja
Publication of JP2010259439A5 publication Critical patent/JP2010259439A5/ja
Pending legal-status Critical Current

Links

JP2010148212A 2001-04-05 2010-06-29 改良された遺伝子発現 Pending JP2010259439A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US28160501P 2001-04-05 2001-04-05
GB0108605A GB0108605D0 (en) 2001-04-05 2001-04-05 Improved gene expression
GB0109335A GB0109335D0 (en) 2001-04-17 2001-04-17 Improved gene expression
US29867501P 2001-06-15 2001-06-15

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2009266880A Division JP2010042033A (ja) 2001-04-05 2009-11-24 改良された遺伝子発現

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011142362A Division JP2011193881A (ja) 2001-04-05 2011-06-27 改良された遺伝子発現

Publications (2)

Publication Number Publication Date
JP2010259439A JP2010259439A (ja) 2010-11-18
JP2010259439A5 true JP2010259439A5 (https=) 2011-08-18

Family

ID=27447937

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2002580040A Pending JP2005500019A (ja) 2001-04-05 2002-04-05 改良された遺伝子発現
JP2008243399A Pending JP2009017886A (ja) 2001-04-05 2008-09-22 改良された遺伝子発現
JP2009266880A Pending JP2010042033A (ja) 2001-04-05 2009-11-24 改良された遺伝子発現
JP2010148212A Pending JP2010259439A (ja) 2001-04-05 2010-06-29 改良された遺伝子発現
JP2011142362A Pending JP2011193881A (ja) 2001-04-05 2011-06-27 改良された遺伝子発現

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2002580040A Pending JP2005500019A (ja) 2001-04-05 2002-04-05 改良された遺伝子発現
JP2008243399A Pending JP2009017886A (ja) 2001-04-05 2008-09-22 改良された遺伝子発現
JP2009266880A Pending JP2010042033A (ja) 2001-04-05 2009-11-24 改良された遺伝子発現

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011142362A Pending JP2011193881A (ja) 2001-04-05 2011-06-27 改良された遺伝子発現

Country Status (9)

Country Link
EP (2) EP1373535B1 (https=)
JP (5) JP2005500019A (https=)
CN (1) CN1500147B (https=)
AT (1) ATE460493T1 (https=)
AU (1) AU2002242872B2 (https=)
CA (1) CA2443275C (https=)
DE (1) DE60235616D1 (https=)
ES (1) ES2339428T3 (https=)
WO (1) WO2002081677A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7812148B2 (en) 2001-04-05 2010-10-12 Millipore Corporation Vectors comprising CpG islands without position effect varigation and having increased expression
US9057079B2 (en) 2003-02-01 2015-06-16 Emd Millipore Corporation Expression elements
ATE453716T1 (de) 2004-08-03 2010-01-15 Geneart Ag Verfahren zur modulation der genexpression durch änderung des cpg gehalts
DE602006008752D1 (de) * 2005-03-05 2009-10-08 Millipore Corp Neue regulatorische elemente enthaltende vektoren
GB0504587D0 (en) 2005-03-05 2005-04-13 Ml Lab Plc Vectors comprising guinea pig CMV regulatory elements
GB0509965D0 (en) 2005-05-17 2005-06-22 Ml Lab Plc Improved expression elements
US20080124760A1 (en) 2006-07-26 2008-05-29 Barbara Enenkel Regulatory Nucleic Acid Elements
CN104531699B (zh) * 2014-10-09 2017-03-15 河南农业大学 一种增强外源基因表达的猪的ucoe调控元件片段
EP3601542A4 (en) * 2017-03-19 2021-01-13 Applied Stemcell, Inc. NEW INTEGRATION SITES AND THEIR USES
US11781146B2 (en) 2018-05-24 2023-10-10 National University Corporation Hokkaido University Vector including a translation-impaired dihydrofolate reductase gene cassette and ubiquitously acting chromatin opening element
CN116790606B (zh) * 2023-08-23 2023-11-07 威瑞生物科技(昆明)有限责任公司 一种遍在染色质开放表达元件、重组表达载体及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000516472A (ja) 1996-08-16 2000-12-12 メディカル リサーチ カウンシル 組織特異的遺伝子発現を与える自己複製型エピソーム性発現ベクター
AU771111B2 (en) * 1998-07-21 2004-03-11 Emd Millipore Corporation A polynucleotide comprising a ubiquitous chromatin opening element (UCOE)
KR100996016B1 (ko) * 2000-09-20 2010-11-22 밀리포어 코포레이션 폴리뉴클레오티드

Similar Documents

Publication Publication Date Title
JP2010259439A5 (https=)
Mayrhofer et al. Use of minicircle plasmids for gene therapy
JP7263327B2 (ja) 細胞の遺伝子修飾のための非組込みdnaベクター
JP2009539367A5 (https=)
KR20140137455A (ko) 인공 핵산 분자
RU2016128077A (ru) Доставка, применение и применения в терапии систем и композиций crispr-cas для лечения обусловленных hbv и вирусных заболеваний и нарушений
JP7592493B2 (ja) 治療用タンパク質の標的細胞に特異的な産生のための、および、標的細胞に関連する疾患、疾病、または障害の処置のための、融合性脂質ナノ粒子、および、融合性脂質ナノ粒子の製造方法と使用方法
CA2967990A1 (en) Rna guided eradication of human jc virus and other polyomaviruses
KR20160104062A (ko) 인공 핵산 분자
CN113166777B (zh) 含有AIMP2-DX2和miR-142的靶核酸的载体及其用途
WO2018185110A1 (en) Novel expression vectors and uses thereof
WO2021042944A1 (zh) 肌肉靶向的微环dna基因治疗
JP5486502B2 (ja) 癌治療用の多数の発現カセットを含む構造体
WO2017137493A1 (en) Synthetic promoters and uses thereof
EP3920888A2 (en) Fusogenic lipid nanoparticles for the target cell-specific production of rapamycin inducible therapeutic proteins
JP2015501642A5 (https=)
RU2326942C1 (ru) Способ создания рекомбинантного аденовируса птиц для вакцинации и генной терапии
KR101399077B1 (ko) 아데닐레이트 싸이클라제 활성화 폴리펩타이드 1 (뇌하수체)의 유전자를 함유하는 자궁경부암세포의 증식 억제용 재조합벡터 및 자궁경부암 치료용 약학 조성물
ES2954867B2 (es) Acido nucleico y su uso en el tratamiento del sarcoma de ewing
CN116926043B (zh) 一种dCasX蛋白核酸酶、重组载体及其应用
US12329793B2 (en) Modified adenovirus and medicine comprising same
KR102626543B1 (ko) AIMP2-DX2 및 miR-142의 표적 핵산을 포함하는 재조합 벡터
WO2008074189A1 (en) A recombinant adenovirus comprising recombinant khp50 gene and preparation method and uses thereof
JP2016160249A (ja) 腫瘍溶解改変アデノウイルス、疾患治療用改変ウイルス及びこれらを含むウイルス製剤
Zeng et al. Therapeutic effect of targeted Fas-expressing adenoviruses method combining γδ T cells in a mouse model of human ovarian carcinoma